Russia’s Enteromix cancer vaccine, developed using mRNA technology, has shown 100 percent efficacy in early trials. Not yet approved for clinical use, it offers a personalised approach to training the immune system to target cancer cells
  • venusaur@lemmy.worldEnglish
    18·
    4 months ago

    Big Pharma will make sure this doesn’t see the light of day any time soon and RFK and his ilk will help them do it.